Skip to content

A Clinical Study To Evaluate The Efficacy Of Aragvadhadi Kwath Yonidhavan In Kaphaj Yonivyapad With Special Reference To Vulvovaginal Candidiasis

An Open Randomized Control Clinical Trial TO Evaluate The Efficacy Of Aragvadhadi Kwath Yonidhavan In Kaphaj Yonivyapad With Special Reference To Vulvovaginal Candidiasis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104229
Enrollment
64
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere Health Condition 2: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Rahila Nawsheen Afsar Khan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married Patients having Kaphaj Yonivyapad i.e having following signs and symptoms 2. Yonigata shweta picchil strav, Yoni kandu Yonigat alpavedana 3. Patient selection of vaginal candidiasis will be confirmed after doing KOH Test

Exclusion criteria

Exclusion criteria: 1. Unmarried female patients. 2. Known cases of sexually transmitted diseases. 3. Uncontrolled DM & HTN. 4. Pregnant women. 5. Cervical polyp and cervical erosion. 6. Patients with intolerable severe pain (VAS scale of 8 to 10) will be excluded.

Design outcomes

Primary

MeasureTime frame
Aragvadhadi kwath yonidhavan is effective in Kaphaj Yonivyapad w.s.r.to VulvoVaginal candidiasis.Timepoint: 7 days

Secondary

MeasureTime frame
1. Aragvadhadi kwath yonidhavan for 7 days increases pH of vaginaTimepoint: Follow up 1st 3rd 7th day during treatment

Countries

India

Contacts

Public ContactDr Dilip Vitthal Katare

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta

drdilipkatareashta@gmail.com9881215521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026